28Feb 2025
OPAL Enhances Outcomes in Acute-on-Chronic Liver Failure Patients

OPAL Enhances Outcomes in Acute-on-Chronic Liver Failure Patients

OPAL significantly improves liver function and clinical scores in ACLF patients. In this study with 87 patients (22 OPAL, 41 Prometheus, 24 hemodialysis), OPAL reduced bilirubin (p = 0.0001) and creatinine (p = 0.049) levels, and significantly lowered the MELD score (p = 0.001) and CLIF-C ACLF score (p = 0.0005). OPAL and Prometheus showed stronger reductions in biochemical variables than SMT, with higher survival rates at 14 and 30 days in Prometheus (p = 0.0008 and 0.03).

  • #gastroenterology

Like

Save

Share